Document is current

Article History

Received: 24 March 2025

Revised: 18 August 2025

Accepted: 25 August 2025

First Online: 11 September 2025

Declarations

:

: N.F. has received honoraria for consulting, advisory roles, speakers’ bureau participation, travel, and/or research grants from Merck Sharp & Dohme (MSD), Merck, Novartis, AstraZeneca, Roche, Menarini Group, Daiichi Sankyo, GlaxoSmithKline (GSK), Gilead, Sysmex, Veracyte Inc., Sakura, Leica Biosystems, Lilly, Pfizer, Abbvie. E. G-R. has received advisory fees, honoraria, travel accommodations/expenses, grants, and/or non-financial support from AstraZeneca, Exact Sciences, GSK, Illumina, MSD, Novartis, Roche, and Thermo Fisher Scientific. U.M. from Boehringer Ingelheim, Roche, MSD, Amgen, Thermo-Fisher Scientific, Eli Lilly & Company, Diaceutics, GSK, Merck, AstraZeneca, Janssen, Diatech, Novartis, and Hedera. These companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and/or in the decision to publish the results. All other authors declare no potential conflicts of interest.